- de Sousa, Diana;
- Poupardin, Rodolphe;
- Villeda, Saul;
- Fröhlich, Thomas;
- Frey, Vanessa;
- Staffen, Wolfgang;
- Mrowetz, Heike;
- Altendorfer, Barbara;
- Unger, Michael;
- Iglseder, Bernhard;
- Paulweber, Bernhard;
- Trinka, Eugen;
- Cadamuro, Janne;
- Drerup, Martin;
- Schallmoser, Katharina;
- Aigner, Ludwig;
- Kniewallner, Kathrin;
- Schroer, Adam
Introduction: Alzheimers disease (AD) and aging are associated with platelet hyperactivity. However, the mechanisms underlying abnormal platelet function in AD and aging are yet poorly understood. Methods: To explore the molecular profile of AD and aged platelets, we investigated platelet activation (i.e., CD62P expression), proteome and transcriptome in AD patients, non-demented elderly, and young individuals as controls. Results: AD, aged and young individuals showed similar levels of platelet activation based on CD62P expression. However, AD and aged individuals had a proteomic signature suggestive of increased platelet activation compared with young controls. Transcriptomic profiling suggested the dysregulation of proteolytic machinery involved in regulating platelet function, particularly the ubiquitin-proteasome system in AD and autophagy in aging. The functional implication of these transcriptomic alterations remains unclear and requires further investigation. Discussion: Our data strengthen the evidence of enhanced platelet activation in aging and provide a first glimpse of the platelet transcriptomic changes occurring in AD.